InsidersTradesSigma
Track the HighTide Therapeutics, Inc. - B stock price and the full directors' dealings record of the company, a listed equity based in Hong Kong. Shares are quoted on the HK market, under the authority of HKEX. Operating in the Health Care sector, HighTide Therapeutics, Inc. - B has published 7 public disclosures. Market capitalisation: €1.3bn. The latest transaction was reported on 8 May 2026 (Sale). Among the most active insiders: MA Lixiong. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
HighTide Therapeutics, Inc. - B is a company focused on the healthcare and pharmaceutical sector. It is listed on the XHKG market.